Molecular Templates to Present a Corporate Overview at the Cowen & Company 39th Annual and the Oppenheimer & Co. 29th Annual Health Care Conferences

AUSTIN, Texas, March 05, 2019 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM), a clinical stage biopharmaceutical company focused on the discovery and development of Engineered Toxin Bodies (ETBs), a new class of targeted biologic therapies that possess unique mechanisms of action in oncology, today announced that management will provide a corporate overview at the Cowen & Company 39th Annual Health Care Conference, and the Oppenheimer & Co., 29th Annual Health Care Conference.

Cowen & Company 39th Annual Health Care Conference
Date: Monday, March 11
Time: 3:30pm Eastern Time

Oppenheimer & Co 29th Annual Health Care Conference
Date: Tuesday, March 19
Time: 8:00am Eastern Time

Molecular Templates is focused on the discovery, development and commercialization of next-generation immunotoxins called Engineered Toxin Bodies (ETBs) for the treatment of cancers and other serious diseases.  For additional information, please visit Molecular Templates’ website at

Investor Contact:
Adam Cutler
Chief Financial Officer

Source: Molecular Templates, Inc.


Source: Molecular Templates, Inc.